September
23
TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate
Initiating clinical trials to evaluate investigational toll-like receptor 9 agonist, SD-101, in patients with...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.